Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 52Leukemia, Myeloid, Acute 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma 23Burkitt Lymphoma 16Leukemia, Monocytic, Acute 15Leukemia, Myelomonocytic, Acute 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Congenital Abnormalities 12Leukemia, Biphenotypic, Acute 9Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Eosinophilic, Acute 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Recurrence 2Neutropenia 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Etoposide 2prednylidene 1deltacortene 1daratumumab 1carmustine, poliferprosan 20 drug combination 1Vincristine 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Plasmablastic Lymphoma × Cytarabine × Clear all
NCT02797470 2026-05-18

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

AIDS Malignancy Consortium

Phase 1/2 Active not recruiting
11 enrolled 9 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, HIV Infections, Lymphoma, T-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡